PMID- 18319560
OWN - NLM
STAT- MEDLINE
DCOM- 20080523
LR  - 20221207
IS  - 1343-1420 (Print)
IS  - 1343-1420 (Linking)
VI  - 55
IP  - 1-2
DP  - 2008 Feb
TI  - Problems in three Japanese drug users with Human Immunodeficiency Virus 
      infection.
PG  - 156-60
AB  - Numbers of individuals infected with Human Immunodeficiency Virus (HIV) are 
      increasing in Japan. The majority of them are Men who have sex with men and a 
      part of them take drugs as 'Sex drug' at their sexual intercourse. Especially, 
      Amyl nitrite, Methamphetamine, 5-methoxy-N, N-diisopropyltryptamine (5-MeO-DIPT; 
      Foxy), and 3, 4-methylenedioxy- methamphetamine (MDMA; Ecstasy) are used, and 
      they sometimes cause the physical and mental disorders. However, the actual drug 
      inducing troubles among Japanese HIV-infected drug users had not yet been 
      discussed enough. In this report, we describe three cases with HIV infection; a 
      case developed severe neuroleptic malignant syndrome (NMS) after taking 
      5-MeO-DIPT, a case with persistent convulsion due to multiple drug intake and a 
      case with rhabdomyolysis due to the non-subjective methamphetamine intake. 
      Through these cases, we raise and discuss several underlying problems associated 
      with drug use among HIV-infected individuals.
FAU - Kuwahara, Takeshi
AU  - Kuwahara T
AD  - Department of Pharmacy, Osaka National Hospital, National Hospital Organization, 
      Osaka, Japan.
FAU - Nakakura, Takahiro
AU  - Nakakura T
FAU - Oda, Sachiko
AU  - Oda S
FAU - Mori, Masahiko
AU  - Mori M
FAU - Uehira, Tomoko
AU  - Uehira T
FAU - Okamoto, Gaku
AU  - Okamoto G
FAU - Yoshino, Munehiro
AU  - Yoshino M
FAU - Sasakawa, Atsushi
AU  - Sasakawa A
FAU - Yajima, Keishiro
AU  - Yajima K
FAU - Umemoto, Aiko
AU  - Umemoto A
FAU - Takada, Kiyonori
AU  - Takada K
FAU - Makie, Toshio
AU  - Makie T
FAU - Yamamoto, Yoshihiko
AU  - Yamamoto Y
LA  - eng
PT  - Case Reports
PT  - Journal Article
PL  - Japan
TA  - J Med Invest
JT  - The journal of medical investigation : JMI
JID - 9716841
RN  - 12D06G8W8E (5-methoxy-N,N-diisopropyltryptamine)
RN  - 3VMW6141KC (5-Methoxytryptamine)
RN  - 44RAL3456C (Methamphetamine)
RN  - 8017-89-8 (Amyl Nitrite)
RN  - KE1SEN21RM (N-Methyl-3,4-methylenedioxyamphetamine)
SB  - IM
MH  - 5-Methoxytryptamine/adverse effects/analogs & derivatives
MH  - Adult
MH  - Amyl Nitrite/adverse effects
MH  - Antiretroviral Therapy, Highly Active
MH  - Asian People
MH  - Drug Interactions
MH  - HIV Infections/*complications/drug therapy
MH  - Humans
MH  - Male
MH  - Methamphetamine/adverse effects
MH  - N-Methyl-3,4-methylenedioxyamphetamine/adverse effects
MH  - Neuroleptic Malignant Syndrome/*etiology
MH  - Rhabdomyolysis/*etiology
MH  - Seizures/*etiology
MH  - Substance-Related Disorders/*complications
EDAT- 2008/03/06 09:00
MHDA- 2008/05/24 09:00
CRDT- 2008/03/06 09:00
PHST- 2008/03/06 09:00 [pubmed]
PHST- 2008/05/24 09:00 [medline]
PHST- 2008/03/06 09:00 [entrez]
AID - JST.JSTAGE/jmi/55.156 [pii]
AID - 10.2152/jmi.55.156 [doi]
PST - ppublish
SO  - J Med Invest. 2008 Feb;55(1-2):156-60. doi: 10.2152/jmi.55.156.